REGN logo

REGN Stock Overview

Profile

Full Name:

Regeneron Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 2, 1991

Description:

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes drugs for the treatment of various diseases - eye diseases, allergies, infections, cardiovascular diseases, metabolic diseases, inflammatory diseases, oncology, and other rare diseases. The company was founded in 1988, with headquarters located in Tarrytown, New York. Currently, Regeneron has seven products that have received marketing approval and are sold in collaboration with Bayer and Sanofi (based on licensing agreements).

Key Details

Price

$723.85

Annual Revenue

$14.20 B(+8.27% YoY)

Annual EPS

$38.34(+10.27% YoY)

Beta

0.72

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 4, 2025

Recent annual earnings:

Feb 4, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 20, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 5, 25 Leerink Partners
Outperform
Feb 5, 25 Baird
Neutral
Jan 28, 25 Citigroup
Neutral
Jan 27, 25 Piper Sandler
Overweight
Jan 16, 25 UBS
Neutral
Jan 14, 25 Citigroup
Neutral
Jan 10, 25 Wells Fargo
Overweight
Jan 8, 25 Truist Securities
Buy
Jan 7, 25 Bernstein
Outperform
Dec 17, 24 Canaccord Genuity
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Regeneron Pharmaceuticals?
  • Does Regeneron Pharmaceuticals pay dividends?
  • What sector is Regeneron Pharmaceuticals in?
  • What industry is Regeneron Pharmaceuticals in?
  • What country is Regeneron Pharmaceuticals based in?
  • When did Regeneron Pharmaceuticals go public?
  • Is Regeneron Pharmaceuticals in the S&P 500?
  • Is Regeneron Pharmaceuticals in the NASDAQ 100?
  • Is Regeneron Pharmaceuticals in the Dow Jones?
  • When was Regeneron Pharmaceuticals's last earnings report?
  • When does Regeneron Pharmaceuticals report earnings?
  • Should I buy Regeneron Pharmaceuticals stock now?

What is the ticker symbol for Regeneron Pharmaceuticals?

The ticker symbol for Regeneron Pharmaceuticals is NASDAQ:REGN

Does Regeneron Pharmaceuticals pay dividends?

Yes, Regeneron Pharmaceuticals pays dividends. The last payment was $0.88, with an ex-dividend date on February 20, 2025

What sector is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is in the Healthcare sector

What industry is Regeneron Pharmaceuticals in?

Regeneron Pharmaceuticals is in the Biotechnology industry

What country is Regeneron Pharmaceuticals based in?

Regeneron Pharmaceuticals is headquartered in United States

When did Regeneron Pharmaceuticals go public?

Regeneron Pharmaceuticals's initial public offering (IPO) was on April 2, 1991

Is Regeneron Pharmaceuticals in the S&P 500?

Yes, Regeneron Pharmaceuticals is included in the S&P 500 index

Is Regeneron Pharmaceuticals in the NASDAQ 100?

Yes, Regeneron Pharmaceuticals is included in the NASDAQ 100 index

Is Regeneron Pharmaceuticals in the Dow Jones?

No, Regeneron Pharmaceuticals is not included in the Dow Jones index

When was Regeneron Pharmaceuticals's last earnings report?

Regeneron Pharmaceuticals's most recent earnings report was on Feb 4, 2025

When does Regeneron Pharmaceuticals report earnings?

The next expected earnings date for Regeneron Pharmaceuticals is May 2, 2025

Should I buy Regeneron Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions